Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.
about
Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Erythrocyte Inosine triphospha ...... ntiretroviral therapy for HIV.
@en
Erythrocyte Inosine triphospha ...... ntiretroviral therapy for HIV.
@nl
type
label
Erythrocyte Inosine triphospha ...... ntiretroviral therapy for HIV.
@en
Erythrocyte Inosine triphospha ...... ntiretroviral therapy for HIV.
@nl
prefLabel
Erythrocyte Inosine triphospha ...... ntiretroviral therapy for HIV.
@en
Erythrocyte Inosine triphospha ...... ntiretroviral therapy for HIV.
@nl
P2093
P2860
P50
P1433
P1476
Erythrocyte Inosine triphospha ...... antiretroviral therapy for HIV
@en
P2093
Aimée D C Paulussen
Bettina E Hansen
Bianca J C van den Bosch
Jolanda A Schippers
Jörgen Bierau
Mathie P G Leers
Selwyn H Lowe
P2860
P304
P356
10.1371/JOURNAL.PONE.0191069
P407
P577
2018-01-12T00:00:00Z